4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-049359
Chief Operating Officer sold 1,635 shares at $10.41 ($17,020)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2023-09-12 | Sale | −1,635 | $10.41 | $17,020 | 107,216 | D |
| Open-market sales · 1,635 sh · avg $10.41 · $17,020 | |||||||
Loading xslF345X05/doc4.xml…